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INTRODUCTION
Enterococci  are Gram positive,  facultative anaerobic  organisms 
that were previously considered to be of the genus streptococci (Group D). 
Later  they  were  found  to  have  different  nucleic  acids  by   hybridisation 
technique and were separated into their own class in 1984. 
Enterococci comprise a significant portion of the normal flora of 
the  gastrointestinal  tract  with  some  also  being  found  on  the  skin  in 
oropharyngeal  and  vaginal  secretions  and  in  perineal  area103.  Enterococcal 
infections are most commonly found in urinary tract infections (16%) and 8% 
of  all  bacteremias.  Endocarditis,  meningitis,  neonatal  sepsis,  respiratory 
infections  are  less  commonly  attributed  to  enterococcal  organisms103.  Most 
human isolates are due to either E. faecalis (74-90%) or E .faecium (5-16%). 
Occasionally,  human  infections  can  be  due  to  Enterococcus  raffinosus, 
Enterococcus casseliflavus, Enterococcus durans, or Enterococcus avium55.
Enterococci  are  now  prominent  as  one  of  the  emerging 
nosocomial  pathogens,  ranking  second  only  to  E.coli  in  total  nosocomial 
infections  accounting  for  more  than  12%  of  all  cases.  The  problem  of 
nosocomial  enterococcal   infection  is  compounded  by  multiple  antibiotic 
resistance.  Their  resistance  to commonly  used antimicrobial  agents  and the 
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ease with which they appear to attain and transfer resistant genes, give  rise to 
enterococci  with  high  level  aminoglycoside   resistance,  β lactamase 
production & glycopeptide resistance 103.                                              
Over the past 2 decades there has been an increasing number of 
reports of Enterococcus species with induced resistance to multiple antibiotics, 
and therapeutic options have become increasingly limited. The first evidence 
of  high-level  resistance  of  Enterococcus  species  to  streptomycin  and 
gentamicin  (minimum  inhibitory  concentration  [MIC]  >  2,000  µg/L)  was 
documented  in  the  1970s  and  during  the  1980s  the  prevalence  of  these 
resistant strains increased dramatically in several locales in North America and 
Europe. High-level aminoglycoside resistance eliminates the option of using 
aminoglycosides in combination with cell-wall active agents (e.g., penicillin or 
ampicillin) for synergistic activity.Resistance to ampicillin is being observed 
with increasing frequency and may be due to a decreased ability to bind to 
penicillins or to the production of β lactamase by the microorganism. 
The  development  of  resistance  to  vancomycin,  which  is 
potentially much more problematic, was first reported in Europe in 1986.Since 
then,  outbreaks of Vancomycin resistant  enterococci  (VRE) infections have 
been described in several institutions and other health setting in the United 
States. The mechanisms of resistance to vancomycin have been described,but 
the concern from a clinical perceptive is  the loss  of  vancomycin and other 
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glycopeptide antibiotics for the treatment of serious enterococcal infections. 
With  an  increasing  incidence  of  Enterococcus  species  resistant  to  both 
penicillins and aminoglycosides, the addition of vancomycin resistance would 
severely  limit  therapeutic  options.  The  vancomycin  resistance  trait  in 
Enterococcus species is transferable, and perhaps the greatest threat of VRE is 
the  potential  emergence  of  vancomycin  resistance  in  methicillin-resistant 
Staphylococcus aureus .
The  clinically  important  Enterococci  are  E.faecalis  and 
E.faecium. In these species, vancomycin resistance is associated with the Van 
A, Van B Genes, Van D or Van E gene cluster. Van A and  Van B genes are 
acquired  through   the  transfer  of  plasmids  or  transposons.  The  VanA 
phenotype is highly resistant to both vancomycin (MIC of 64 µg/mL or more) 
and  to  teicoplanin,  the  investigational  glycopeptide  (MIC of  16  µg/mL  or 
more).  The  Van  B  phenotype  shows  moderate  to  high-level  resistance  to 
vancomycin (MIC of 32 to 256 µg/mL) but  usually  remains susceptible  to 
teicoplanin (MIC of less than 1 µg/mL). These two phenotypes are the most 
prominent  and  are  seen  primarily  in  E  faecium,  but  they  also  occur  in  E 
faecalis. A third phenotype, VanC, shows low-level resistance to vancomycin 
(MIC of 8 to 32 µg/mL) without teicoplanin resistance; this phenotype is seen 
primarily in E gallinarium and E casseliflavus. Vancomycin resistance occurs 
when  proteins  are  synthesized  by  the  resistant  enterococci,  called  "VanA," 
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"VanB," and "VanC." These proteins produce resistance by acting as ligases 
that  alter  the  cell-wall  precursors,  which  are  the  targets  of  vancomycin. 
E.gallinarum  and  E.casseliflavus  possess  intrinsic,  non  transferable 
vancomycin  resistance  encoded  by  Van  C1 and  Van  C2 ligase  genes 
respectively.  These  species  rarely  cause  infections  and  are  associated  with 
transmission and hospital outbreak. Hence,  for infection control practices and 
prevention  of  person  to  person  transmission  ,detection  of  Vancomycin 
resistant Enterococci and speciation is necessary. High Level Aminoglycoside 
resistance (HLAR) has been observed in E.faecalis and E.faecium. 
                         Few virulence factors have been identified like haemolysin,  
gelatinase, aggregation substances and surface protein. Haemolysin increases 
the  virulence  of  E.faecalis  in  infection  models  of  different  animal species. 
Gelatinase  producing  strains  resulted  in  more  severe  clinical  findings  in 
experimental endocarditis model. Aggregation substances, is a surface protein 
encoded  by  sex-pheremone  responsive  plasmids,  increases  the  number  of 
bacteria adhering to renal and intestinal epithelial cells, suggesting aggregation 
substances is  important for colonisation and translocation of host tissues by 
E.faecalis66. 
Enterococcal  surface protein was found in E.faecalis, strain that 
caused  multiple  infections  within  a  hospital  ward.  A  variant  Enterococcal 
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surface protein gene was also found in Vancomycin Resistant Enterococcus 
faecium spreading in  hospitals 41.  
                      Enterococci account for as many as 10% of cases of neonatal 
bacteremia  and  septicemia.  Incidence  of  neonatal  enterococcal  septicemia 
increased from 0.12 per 1000 live births in 1982 to 0.8 per 1000 live births in 
1986.  Enterococcus may cause early-onset  (within 7 days of birth)  or  late-
onset (>7 days) neonatal sepsis.  Early-onset sepsis caused by enterococci is 
milder than that caused by group B streptococci. Most cases of enterococcal 
bacteremia in neonates are nosocomial. Central venous catheters, necrotizing 
enterocolitis, and intra-abdominal surgery are risk factors.  Enterococcus may 
cause focal skin and soft tissue infections, meningitis, and conjunctivitis in the 
neonate. Most neonatal infections are caused by E. faecalis55.
           Neonatal septicemia remains one of the most important causes of 
mortality  despite  considerable  progress  in  hygiene,  introduction  of  new 
antimicrobial agents, and advanced measures for early diagnosis and treatment 
.Group B streptococcal disease is the most important cause of neonatal sepsis 
in Europe and North America,but there is a preponderance of Gram-negative 
organisms  in  tropical  and developing countries.As neonatal  septicemia  is  a 
life-threatening  emergency  and  delay  in  diagnosis  and  treatment  with 
appropriate  antibiotics  may  have  devastating  consequences  and  hence 
surveillance is needed to identify the common signs and pathogens of neonatal 
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septicemia  as  well  as  the  antibiotic  sensitivity  patterns  for  the  agents  of 
septicemia in a particular area3.
        Clinical  presentations  of  patients  with culture-proven serious 
neonatal bacterial infection were respiratory distress (47%), lethargy (40%), 
jaundice (40%), fever (36%) and poor feeding (27%). Respiratory distress is 
significantly  more  common in early-than late-onset  septicemia.  Males  have 
been reported to be 2 to 5 fold more likely than females to develop septicemia. 
History of unclean vaginal examination was associated with a 10% incidence 
of deep infection in one study 3. 
   Risk  factors  for  acquisition  of  VRE  and  enterococcal  infections 
include history of the following:
• Prolonged hospitalization
• Long stay in ICU
• Surgical reexploration following liver transplantation
• Prior use of antibiotics, mainly vancomycin and cephalosporins
• Immunocompromised state
• Breakdown  of  normal  physical  barriers  (eg,  gastrointestinal  tract, 
skin, urinary tract)
• Neurosurgical procedures and use of neurosurgical devices   54
11
          As Enterococcal  infections are one of  the leading cause of 
nosocomial infection,this study was focussed on the isolation of enterococcus 
from the various clinical samples collected from Government Rajaji Hospital 
(GRH)  and to speciate them and to analyse the common species responsible 
for  infections  wardwise,specimenwise,sexwise  and  age  wise.  Further  the 
common  factor  responsible  for  the  emergence  of  this  infection  was  also 
studied.
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AIM  AND OBJECTIVES
• To Isolate Enterococcus from hetrogenous samples collected 
from GRH by culture and confirmation by biochemical tests.
• To speciate Enterococcus and to study their etiological role.
• To study the antibiogram of the isolated species.
• To Identify predisposing factors for Enterococcal infections.
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REVIEW OF LITERATURE
Koneman’s Textbook of Diagnostic Microbiology ,6th edition has 
stated  that  the  genus  Enterococcus  includes  the  enterococcal  members 
previously  classified  with  the  group  D  streptococci.These  organisms  are 
normal residents of the gastrointestinal and biliary tracts .They are becoming 
increasingly  important  agents  of  human  disease,largely  because  of  their 
resistance  to  antimicrobial  agents  to  which other  streptococci  are  generally 
susceptible.20
The term “enterocoque”,was first used by  Thiercelin et al   in 
1899.Thiercelin published  a paper in French, ‘Sur un diplocoque saprophyte 
de l'intestin susceptible de devenir’in which he used the term to describe the 
Gram positive cocci in pairs that he observed to be present in the faeces.92,93 
In  1906,  Andrews  and  Horder  et  al first  used  the  term 
Streptococcus faecalis6,27.
In  1919,  Orla  –  Jensen  et  al described  a  second  organism 
S.faecium which differed from the fermentation patterns of S.faecalis 64 . 
In  1935  ,Sherman  and  wing  et  al proposed  a  third  species 
Streptococcus durans84 . 
In  1937,  Sherman  et  al  stated  that  durans  was  similar  to 
S.faecalis but had less fermentation activity84. 
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In 1938 ,Sherman et al used the term “enterococcal group” to 
describe  Streptococci  that  grew at  10oC and 45oC,  grew in  broth  with  pH 
adjusted to 9.6 and in broth containing 6.5% NaCl and survived heating to 
60oC for 30 minutes84,93.
In 1967, Nowlan and Deibal et al added Streptococcus avium to 
enterococcal group63,93. 
In  1970,  Kalina  et  al proposed  a  separate  genus  for  the 
Enterococcal streptococci be established and suggested that, based on cellular 
arrangement and phenotypic characteristics, S.faecalis and S.faecium and the 
subspecies of these 2 taxons be named Enterococcus93 .
In 1984, Scheifer and Kilpper Balz et al proved that by genetic 
evidence like DNA-DNA and DNA rRNA hybridization studies and by 16 S 
rRNA studies  that  S.faecalis  and S.  faecium were different  from the  other 
members of the genus to merit a separate genus 83.
         CKJ  Paniker  and  R.  Ananthanarayan,  Text  book  of 
Microbiology,  7th edition  has described the genus  Streptococci  as  follows. 
Streptococci  are  first  divided  into  obligate  anaerobes  and  facultative 
anaerobes.  The  former  are  designated  Peptostreptococci.  The  aerobic  and 
facultative  anaerobic  Streptococci  are  classified  on  the  basis  of  their 
haemolytic  properties.  Brown  (1919)  categorised  them  into  three  varieties 
based on their growth in 5% horse blood agar13.
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Alpha  (α)  haemolytic  Streptococci  produce  a  greenish 
discolouration with partial haemolysis around the colonies. The zone of lysis is 
small (1 or 2mm wide) with indefinite margins, and unused erythrocytes can 
be made out microscopically within this zone. They are known as “Viridans 
Streptococci”13. Beta  (β)  haemolytic  Streptococci  produce  a  sharply 
defined, clear,colourless zone of haemolysis 2-4mm wide, within which red 
cells  are  completely  lysed.  Most  pathogenic  Streptococci  belong  to  this 
group13. Gamma (γ) or non haemolytic Streptococci produce no change in 
the medium and so are sometimes referred to as “Indifferent Streptococci”. 
They include the faecal Streptococci (Enterococci, Streptococci faecalis) and 
selected species. They are called the “Enterococcus group”13.
                In  1933 Lancefield  et  al classified  Haemolytic  Streptococci 
serologically into groups based on the nature of a carbohydrate (C) antigen on 
the cell wall. These are known as Lancefield groups, twenty of which have 
been identified so far  and named A-V (without I  & J).  Majority of  human 
infections are caused by Group A  β-haemolytic Streptococci.  They may be 
further  subdivided  into  types  based  on  the  protein  (M,T,  and  R)  antigens 
present on the cell surface (Griffith typing)38,13.
Group D Streptococi  can be classified into two groups
 1) The Enterococcus group (Enterococci or faecal Streptococci) which have 
been  reclassified  as  separate  genus,  Enterococcus  containing  for  example 
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E.faecalis,  E.faecium,  E.durans13.  2)  Non  Enterococcal  group,  for  example 
Str.bovis and Str.equinus13.
Beta
                                           (haemolytic streptococci) 
                    Serological Group specific C 
carbohydrate antigen
                                                  20 Lancefield groups 
(ABCDEFGHKLMNOPQRSTUV)
Group A Streptococcus Pyogenes
Serological typing (M Protein Griffith types1,2,3 etc.,)
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O
2
 requirement
Aerobes &facultative anaerobes Obligate anaerobes, Peptostreptococci
Alpha
(the Viridans group)
Gamma 
(The Enterococcus group)
Classified into species by 
physiological and 
biochemical properties
Streptococci
R. R. Facklam, D. S. Sahm, and L. M. Teixeira  et al in the Manual of 
Clinical Microbiology, has described   enterococci as follows.They are Gram-
postive cocci, occuring singly, in pairs, or in short chains  and are facultatively 
anaerobic.They  grow  between  10ºC  and  45ºC  (most  strains),  optimum  at 
35ºC  ,grows  in  broth  containing  6.5% NaCl  and  hydrolyze  esculin  in  the 
presence of 40% bile salts  (bile-esculin medium).Motility  was observed in 
some species .Hydrolysis of leucine-ß-naphthylamide (LAP) and hydrolysis of 
pyrrolidonyl-ß-naphthylamide  (PYR)  occurred  with  the  exception  of  E. 
cecorum, E. columbae, and E. saccharolyticus.They are catalase negative and 
nearly  all  strains  are  homofermentative,  without  gas  production.Glucose 
fermentation results in production of lactic acid.Cell wall-associated glycerol 
teichoic acid antigen is identified as streptococcal group D antigen72. 
                     According to Huycke, et al Enterococci normally inhabit the 
bowel. They are found in the intestine of nearly all animals, from cockroaches 
to humans.In humans, typical concentrations of enterococci in stool are up to 
108 CFU per gram.  Although the oral  cavity and vaginal  tract  can become 
colonized, enterococci are recovered from these sites in fewer than 20% of 
cases. The predominant species inhabiting the intestine varies. Of 14 or more 
enterococcal species, only E. faecalis and E. faecium commonly colonize and 
infect  humans  in  detectable  numbers.  E.  faecalis is  isolated  from 
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approximately 80% of human infections, and E. faecium from most of the rest. 
Infections to other enterococcal species are rare 28. 
                     M.G.Karmakar et al have isolated 52  enterococci ,of which 42 
were E.faecium 45.
                     Adam .N.Treitman et al  have reported  that there is an 
increasing emergence  of enterococci over the past 10 years in their medical 
centre.They  have  stated  that  the  percentage  of  enterococci  identified  as 
E.faecium  has  increased  from  12.7%  to  22.2%  and   the  percentage  of 
E.faecium resistant to vancomycin has gone up from 28.9% to 72.4% 4.
                    Shuqiu Cheng et al have stated that E.faecium is an important 
emerging nosocomial infection .They have devised a PCR assay for the rapid 
identification of E.faecium87.
Patrick  &  Murray et  al in  the  Text  book  of  Manual  of 
ClinicalMicrobiology, 9th edition  has stated that Enterococci are considered to 
be  the  most  abundant  Gram-positive  cocci  colonizing  the  intestine,  with 
E.faecalis being  one  of  the  most  common  bacteria  isolated  from this  site. 
Other  species,  such as  E.faecium as  well  as  E.casseliflavus,  E.durans,  and 
E.gallinarum,  are  also  found  in  variable  proportions  in  the  gastrointestinal 
tract  of  humans.  Since  the  enterococci  are  opportunistic  pathogens,  the 
incidence  of  each  species  found  in  human  infections  probably  reflects  the 
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distribution  of  the  different  species  of  Enterococcus  in  the  human 
gastrointestrinal tract. This site is believed to represent an important reservoir 
for  strains  associated  with disease;  from this  location they  may migrate  to 
cause  infections  and  can  also  disseminate  to  other  hosts  and  to  the 
environment.  Even  though  the  same  enterococcal  species  can  be  found  in 
several different animal species, the information available on the distribution 
of distinct enterococcal species in other sources indicates differences from the 
distribution in humans 66. 
                        Sherwood L Gorbach et al   has said that  Urinary tract 
infections  are  the  most  common  type  of  clinical  disease  produced  by 
enterococci, and urine cultures are the most frequent sources of enterococci in 
the clinical microbiology laboratory. In addition to uncomplicated cystitis or 
pyelonephritis, or both, enterococci have also been shown to cause prostatitis 
and  perinephric  abscess.  Most  enterococcal  urinary  tract  infections  are 
nosocomial and are associated with urinary catheterization or instrumentation, 
or both. There is strong evidence to suggest that the prevalence of nosocomial 
enterococcal urinary tract infections is increasing in a number of hospitals 85. 
Mcneely D.  F  et  al  have reviewed  neonatal  enterococcal 
bacteremia.They have reported an increased number of these infections since 
the  late  1970s  and  the  increased  isolation  of  organisms  resistant  to  many 
commonly  used  antimicrobials  .  Common  characteristics  associated  with 
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enterococcal  bacteremia  included  the  presence  of  a  central  vascular 
catheter,necrotizing enterocolitis and abdominal distension54.  
Susan  L  Fraser,  et  al have  reported  that  Enterococci  cause 
5-15% of all endocarditis cases.This condition usually occurs in older patients. 
Their  presentation  is  typically  subacute.Usually,  left-sided  endocarditis  and 
mitral valve involvement is more common than aortic involvement.E faecalis 
caused most cases of endocarditis. Risk factors include urinary tract infection 
or instrumentation.Most cases of enterococcal bacteremia are not associated 
with  endocarditis.  Indeed,  only  about  1  out  of  50  cases  of  enterococcal 
bacteremia results in endocarditis91 
W. G. Jones, P. S. Barie et al  have done a retrospective study to 
examine the incidence and clinical significance of enterococcal bacteremia in 
burns  patients  with enterococcal  burn-wound  infections. Mortality  was 
significantly greater for bacteremic patients than for patients with enterococcal 
wound infection alone or for burns patients without enterococcal infections99. 
       Shrikiran Hebbar   et al have reported  their experience with a 
case of enterococcal meningitis in a healthy 7 month old infant who did not 
present  with  any  predisposing  factors.They  have   discussed  the  role  of 
enterococci in the pathogenesis of meningitis.According to them, Enterococci 
are clearly unusual etiological agents of bacterial meningitis86. 
21
     Chiara  Iaria   et  al   have  reported  a  case  of  enterococcal 
meningitis  due  to  Enterococcus  casseliflavus.They  have  reviewed  that 
Enterococcal meningitis accounts for only 0.3% to 4% of cases of bacterial 
meningitis which is nevertheless associated with a high mortality rate. It has 
been described most frequently in patients with neurosurgical conditions12.
              Sherwood  L  Gorbach et  al   has  stated  that  most  cases  of 
enterococcal meningitis occur in patients with anatomic defects of the central 
nervous  system,  prior  neurosurgery,  or  head  trauma.  Meningitis  is  a  rare 
complication  of  high-grade  bacteremia  in  patients  with  enterococcal 
endocarditis.  Meningitis  also  occasionally  complicates  enterococcal 
bacteremia  in  patients  with  severe  immunodeficiencies  including  acquired 
immunodeficiency syndrome and acute leukemias. It is also seen in neonatal 
sepsis85.
Stroud,  L.,  J.Edwards et  al   has  said  that  respiratory  tract 
infections  due  to  enterococci  are  exceedingly  unusual.  Although  well-
documented  cases  of  enterococcal  pneumonia  and even lung abscess  exist, 
they usually  occur in patients with severe  and debilitating diseases.  Broad-
spectrum antimicrobial therapy, especially with cephalosporins, coupled with 
enteric feeding in severely debilitated patients has been the setting in which 
some of the rare cases of enterococcal pneumonia have been described90.
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                      James F. Morris et al have stated that Enterococci are rarely 
implicated in the causation of pneumonia or lung abscess. They have reported 
two patients who have developed large lung abscess cavities from enterococcal 
pneumonia.  Combination  of  penicillin  and  aminoglycoside  antimicrobial 
therapy  and drainage with  a  transthoracic  tube  resulted  in  complete  cavity 
closure and healing in these patients 30. 
                Mehrdad  Behnia  et  al   have  said  that  the  most  common 
organisms  isolated  from  empyema  are  Streptococcus  pneumoniae, 
Staphylococcus aureus,  Hemophilus influenzae,  Escherichia coli,  Klebsiella 
pneumoniae,  and species  of  Bacteroides.  Enterococcus is  rarely present  in 
chest infections.They have reported Enterococcus faecalis causing empyema in 
a case of Liver disease56.
Stroud, L., J.Edwards et al   states that Enterococci have clearly 
been documented to cause neonatal sepsis characterized by fever, lethargy, and 
respiratory  difficulty  accompanied  by  bacteremia  or  meningitis,  or  both. 
Although early-onset bacteremia in otherwise normal neonates is characteristic 
of this disease, several nosocomial outbreaks of bacteremia or meningitis, or 
both, due to E.faecium or E.fecalis have been described in premature or low-
birth-weight neonates who had nasogastric tubes and intravascular devices. In 
general, neonates with enterococcal sepsis have responded well to appropriate 
antimicrobial therapy90.
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       Patrick  & Murray   et  al   in  the  Text  book of  Manual  of 
Clinical  Microbiology   have  described  the  laboratory  isolation  of 
enterococci. Trypticase soy – 5% sheep blood agar, brain – heart infusion – 
5% sheep blood agar  or  any blood agar  base  containing  5% animal  blood 
supports  the  growth  of  Enterococci.  Some  strains  of  E.faecalis  are  β - 
hemolytic on agar base containing rabbit or horse blood but non haemolytic in 
the same base media containing sheep blood. If the sample is likely to contain 
gram  negative  bacteria,  bile-esculin  agar  and  azide,  Pfizer  selective 
Enterococcus  medium are  excellent  primary  isolation  media56.  The  azide  –
inhibits  the  Gram – negative  bacteria  and the Enterococci  appear  as  black 
colonies because of hydrolysis of aesulin66. 
                   Bailey & Scott’s Text book of Diagnostic Microbiology, 11th 
edition describe the use of other media such as columbia –colistin – nalidixic 
agar (CAN) or phenyl ethyl alcohol agar (PEA) to isolate Enterococci.  The 
advantage of  CAN over PEA is  that  haemolytic  reaction can be read from 
CAN.  With  increasing  evidence  of  Vancomycin  Resistant  Enterococci, 
Enterococcosel  broth,  brain  heart  infusion  broth  containing  vancomycin 
6µg/ml.,  VRE  selection  medium  (bile  esculin  azide  agar  containing 
vancomycin 6µg/ml) are useful selective media9. 
           Topley & Wilson,  Text book of Microbiology and Microbial 
Infections ,  states that the colonies on blood agar media are usually between 
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1-2 mm in diameter. Some cultures of E.faecalis may be β - hemolytic on agar 
containing  rabbit,  horse  or  human  blood  but  non  haemolytic  on  agar 
containing sheep blood. Some culture of Enterococcus durans are β haemolytic 
regardless of the type of blood used.  All other species  are either  α or non 
haemolytic. Enterococcus casseliflavus, E.mundtii and E.sulfureus produce a 
yellow pigment on blood agar medium. The pigment is detected by using a 
white cotton swab to pick up the growth and examining the swab of yellow 
colour.  In  bile-esculin-azide  medium,  the  colonies  appear  grey  –  white 
surrounded by a black halo93.
                           M.Ford et al have used Cephalexin Aztreonam Agar for the 
selective isolation of Enterococcus faecium.E.faecium was differentiated from 
E.faecalis and E.durans by their ability to ferment arabinose on CAA43.
Jawetz,  Melnick and Adelberg  in the Text  book of  Medical 
Microbiology  have  stated that  resistance  to  the inhibitory  and bactericidal 
activities  of  several  commonly  used  antimicrobial  agents  is  a  remarkable 
characteristic  of  most  of  the  enterococcal  species.  Antimicrobial  resistance 
markers can be either intrinsic or acquired. Intrinsic (or) inherent resistance 
traits  are  present  in  all  or  most  of  the  strains  and  hence  appears  to  be 
chromosomally coded31.  
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Y.A. Marothi   et  al  has  reviewed the enterococcal  resistance. 
Antimicrobial  resistance  in  enterococci  is  of  two  types:  inherent/  intrinsic 
resistance and acquired resistance. Intrinsic resistance is species characteristics 
and thus present in all members of species and is chromosomally mediated. 
Enterococci exhibits intrinsic resistance to penicillinase susceptible penicillin 
(low level),  penicillinase  resistant  penicillins,  cephalosporins,  lincosamides, 
nalidixic  acid,  low level  of  aminoglycoside  and  low level  of  clindamycin. 
Although most  enterococci  are  susceptible  to  co-trimoxazole  in  vitro ,  this 
combination  does  not  work  in  vivo ,  because  enterococci  are  able  to 
incorporate preformed folic acid which enables them to bypass the inhibition 
of folate synthesis produced by co-trimoxazole. On the other hand, acquired 
resistance results from either mutation in DNA or acquisition of new DNA. 
Examples  of  acquired  resistance  include  resistance  to  penicillin  by  β 
-lactamases, HLAR, vancomycin, chloramphenicol,  erythromycin, high level 
of clindamycin, tetracycline and fluroquinolone resistance103.
R. Fontana  et  al in  their  publication  have  described  two 
mechanisms which are responsible for resistance of enterococci to beta-lactam 
antibiotics: alterations of penicillin-binding proteins and production of a beta-
lactamase. The latter has been found in a few clinical isolates of Enterococcus  
faecalis, whereas the former appears to account for resistance in most strains71. 
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Strains expressing high level resistance to aminoglycosides have 
minimal inhibitory concentrations (MIC  ≥ 2000  µg/ml) due to Enterococcal 
aminoglycoside modifying enzymes and cannot be detected by diffusion test 
with conventional discs41. To circumvent this problem, special test using high 
content gentamycin (120 µg) and streptomycin (300 µg) discs were developed 
to  screen for  their  type of  resistance  as  documented  in  strains  of  E.avium, 
E.casseliflavus,  E.gallinarium,  E.raffinosus  and  E.mundtti.  It  is  transposon 
mediated93.
            Vandana A et al  has reported concomitant HLPR and HLAR in 
16%  of  enterococci.Low  level  vancomycin  resistance  was  encountered  by 
them in 3.3% enterococci97.
S.Parvathi,B.Appala  Raju  et  al  have  done  a  comparative 
evaluation  of  β-lactamase  production  in  enterococci  by  Acidometric  and 
clover leaf technique81.
Topley  &  Wilson in  the  Text  book  of  Microbiology  and 
Microbial  Infections  has stated that  strains producing  β lactamase through 
plasmid  mediated  gene,  occur  sporadically.  This  can  be  detected  by  using 
chromogenic cephalorsporin assay93. 
                      Mackie & Mc Cartney in their Text book of Microbiology and 
Microbial  Infections   have  said  that  β-lactamase  production  is  reported  in 
E.faecalis, E.faecium, E.gallinarum & E.raffinosus also. Gene encoding for the 
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Enterococcal β-lactamase is the same gene as found in Staphylococcus aureus. 
The  gene  is  constitutively  expressed  in  Enterococci  and  inducible  in 
Staphylococci.  Because  Enterococci  may  produce  small  amounts  of  the 
enzyme,  they  may  appear  to  be  susceptible  to  penicillin  and ampicillin  by 
routine susceptibility test46. 
                    Patrick & Murray  et al  in the Text book of Manual of 
Clinical Microbiology   has said    that the β-lactamase can be detected using 
a high inoculum and the chromogenic cephalosporin test or by other methods. 
Infections  due  to  β-lactamase  producing  Enterococci  can  be  treated  with 
combination  of  penicillin  and  β lactamase  inhibitor  or  vancomycin  and 
streptomycin when in vitro susceptibility has been demonstrated66.
Rosemeire Cobo Zanella et al  have reviewed the resistance  of 
Vancomycin-resistant  enterococci  (VRE).  Vancomycin-resistant  enterococci 
were  first  reported  in  1988  in  Europe,  and  then  they  have  emerged  and 
disseminated  as  an  important  cause  of  nosocomial  infections  worldwide. 
Glycopeptide  resistance  in  enterococci  is  associated  with  a  variety  of 
phenotypes and genotypes.  Two principal  phenotypes of resistance in VRE 
have  been  described  and  associated   with  nosocomial  infections.  In 
enterococci, the  vanA phenotype is characterized by high-level resistance to 
vancomycin  and  teicoplanin,  whereas  the  VanB phenotype  by  vancomycin 
resistance and teicoplanin susceptibility79.  
28
                  Bell, J. M., Paton, J.C. et al have reviewed   that genes encoding 
the vanA- and vanB-phenotype resistance are located on transposons Tn1546 
and Tn1547, respectively, or in closely related transferable genetic elements. A 
third type of vancomycin resistance, termed VanC, has been known for many 
years  to  be a natural  (intrinsic)  vancomycin  resistance  found in  the motile 
enterococci E. casseliflavus, E. gallinarum, and E. flavescens10.      
    Mandell,  Douglas  &  Bennett  et  al   in  the  Text  book  of 
Principles  and  Practice  of  Infections  has  stated  that  Enterococci  show 
resistance  to  even  oxazolidinones,  a  new  antibiotic  that  shows  excellent 
activity against Gram positive organisms as per the recent reports48.
Johnson et al has stated  that Vancomycin Resistant Enterococci 
(VRE)show susceptibility  to  quinopristin  –  dalfopristin  a  new antibiotic  of 
streptogramin group. Daptomycin, a lipopeptide, a new bactericidal antibiotic 
approved by FDA in 2003 is highly active against most Gram positive cocci, 
including Vancomycin Resistant Enterococcus faecalis33.
Enterococci  often  show  susceptibility  to  Trimethoprim  – 
sulfamethoxazole in vitro testing but these drugs are not effective in treating 
infection. This is because in vivo, Enterococci utilize exogenous folates, thus 
escape inhibition by the drugs48.
Enterococci, being a leading cause of nosocomial infections and 
frequently  exhibiting  multiple  antibiotic  resistance,  typing & subtyping the 
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isolates  is  necessary  as  a  means  of  assisting  infection  control  and 
epidemiological  studies.  It  includes  bacteriocin  typing,  phage  typing,  bio-
chemical  reaction  profiles,  antimicrobial  patterns,  and  serological 
characterisation93.
Bacteriocins are proteins that prevent the growth of other bacteria. 
Among Enterococci, E.faecalis, E.faecium and E.hirae are known to produce 
bacteriocins. These are inhibitors to Listeria monocytogenes, Staphylococcus, 
Lactococcus sp. and other Enterococcus sp. Bacteriocin production is linked to 
conjugative plasmid in some cases.  The haemolytic activity of E.faecalis  is 
linked to bacteriocin activity and both these activities are associated with a 
conjugative plamid93. Haemolysin activity is associated with strain virulence77. 
Bacteriocins  are  used  as  food  preservatives,  used  as  a  typing  system  for 
Enterococci.
 The  virulence  of  enterococci  have  been  reviewed  by  D. 
Morrison et al . Cytolysin ,haemolysin, aggregative substances and adhesins 
are the most studied.    The haemolysin is a cytotoxin that lyses human, horse 
and rabbit erythrocytes. Its production is coded by plasmid  pAD1, which also 
confers bacteriocin production. Production of haemolysin was reported to be 
more common in strains of E.faecalis isolated from human infections than in 
strains  isolated  from  faecal  sources  of  healthy  persons.Haemolysin  and 
aggregative  substance  contributed  to  enhanced  virulence  in  experimental 
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endocarditis.  These  substances  have  an  effect  on  colonisation,  invasion, 
platelet aggregation or fibrin generation 14.
Enterococci  are  capable  of  transmitting  genetic  information  by 
both  plasmid  and  transposon  exchange  among  themselves  and  with  other 
genera. Plasmid exchange is through production of sex pheremones, this was 
observed in E.faecalis77. The  genetic material on plasmids could be either drug 
resistance or virulence genes.
Enterococci are also capable of genetic exchange by conjugative 
transposons, which requires cell to cell contact. Transposons carry resistance 
determinants  for  antimicrobial  agents  such  as  tetracycline,  erythromycin, 
gentamycin, kanamycin, and other aminoglycosides77.
                   Mandell, Douglas & Bennett in the Text book of Principles and 
Practice of Infectious diseases,  6th edition have given a detailed description 
regarding the treatment  of enterococcal  infection.Treatment  of Enterococcal 
infection is complicated . For treating urinary tract infections, peritonitis, and 
wound infections,  that  do not  require any bactericidal  treatment,  ampicillin 
remains the antibiotic of choice.  Vancomycin is the drug of choice for  the 
patients  who  are  allergic  to  penicillin  or  those  with  high  level  penicillin 
resistant  organisms.  90  –  96%  remain  susceptible  to  nitrofurantoin, 
successfully used to treat urinary tract infection. Fosfomycin is also effective. 
Increasing resistance to ciprofloxacin and ofloxacin is  reported in vitro but 
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sparfloxacin,  levofloxacin,  gepafloxacin  and  trovofloxacin  are  more  active. 
Now,  Enterococci  are  exhibiting  resistance  to  erythromycin  and  related 
macrolides. Tetracycline and chloramphenicol may exhibit in vitro activities 
against  these  organisms  and  clinical  failures  of  chloramphenicol  are 
documented.Combination  therapy  is  optimal  for  Enterococcal   endocarditis 
and for meningitis  as well.  Combination of cell  wall  active agents (usually 
penicillin,  ampicillin  or  vancomycin)  with  aminoglycosides  (usually 
streptomycin  or  gentamycin)  have  been  the  standard  for  treatment  of 
Enterococcal  endocarditis  since  the  first  demonstration  of  penicillin  – 
streptomycin  synergy  in  1947.  Several  antimicrobial  agents  show  some 
promise for the therapy of infection due to multiple drug resistant Enterococci 
especially Vancomycin Resistant Enterococci. They include the streptogramin 
combination  quinopristin  –  dalfopristin,  an  oxazolidinone  linezolid,  the 
everninomicin  ziracin,  a  new  semisynthetic  glycopeptide,  LY  333328  and 
ramoplanin, a novel glycolipodesipeptide48.
Richard  L.  et  al  has  said  that  β lactamase  producing  strains 
remain susceptible to vancomycin (and teicoplanin) and to combinations of β 
lactam  and  β lactamase  inhibitors  such  as  ampicillin  –  sulbactam  and 
amoxicillin – clavunlanate77.
Centers  for  Diseases  Control  and  Prevention,  have 
recommended  methods  for  preventing  the  spread  of  vancomycin 
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resistance.The appearance and spread of multiple resistant strains of VRE has 
prompted  the  adoption  of  new  strategies  to  prevent  infection  with  these 
Enterococci in hospitalised patients. 
The recommendations include:-
♦ Guidelines for prudent use of vancomycin
♦ Education of hospital staff
♦ Early detection and prompt reporting of new VRE cases
♦ Implementation of barrier precautions to interrupt nosocomial 
transmission, especially that mediated by the hands of health care 
workers11.
Richard L. Gurret et al  in the Journal of Tropical infectious diseases  has 
said that vancomycin use in the hospital may foster the spread of resistance if 
used inappropriately; hence the HICPAC recommendations promote better 
usage. 
Education of hospital staff is essential for any VRE control effect. The 
importance of person to person spread requires emphasis as does the potential 
role of contaminated surfaces. Fortunately, VRE strains are susceptible to most 
environmental  disinfectants,  but  they  may  be  used  in  accordance  with  the 
manufacturer’s recommended time of exposure77.
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MATERIALS AND METHODS:
This Prospective study was conducted at Government Rajaji Hospital, 
attached to Madurai Medical College after getting ethical clearance from the 
Human Ethical Committee, GRH, headed by the Dean. The period of study 
was 4 months from November 2006 to February 2007 . The study population 
consisted of 200 patients admitted in different wards viz Paediatrics ,General 
Surgery,  Urology  and  Medicine  at  Government  Rajaji  Hospital,Madurai. 
Various specimens like Blood ,Urine, Pus Swab and CSF were collected from 
the patients depending on the clinical symptoms.
INCLUSION CRITERIA
• Septicemic and PUO cases in Paediatric ward .
• Wound infection following burns in Surgery ward.
• Post operative wound infection in Surgical Ward.
• Intraabdominal abscesses in Surgical Ward.
• Cases with Urinary tract infection in Urology Ward
• Meningitis and Endocarditis cases in Medicine ward.
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EXCLUSION CRITERIA
• All other cases from Pediatric ward.
• All other wound infections from Plastic Surgery ward.
• All other abscesses in Surgical ward
• All other cases from Medical Ward
• Other infections in Urology Ward.
General  examination  was  done  on  each  patient.  Basic 
investigations like Hb, TC,  DC, ESR, and Blood sugar were done on each 
patient  and  recorded.  Antibiotics  administered  to  these  patients  with  the 
dosages and the period of administration were noted.
COLLECTION OF  SPECIMENS:-
Blood was collected with strict aseptic precautions. A tourniquet 
was placed above the venepuncture site. Using 70% alcohol, the venepuncture 
site  was  cleaned  in  a  circle  approximately  5  cm  in  diameter  rubbing 
vigorously.  The  alcohol  was  then  allowed to  air  dry.  Next  ,10% povidone 
Iodine was applied and the skin was swabbed concentrically from the centre of 
the venepuncture site outwards. The iodine was allowed to act on the skin for 
atleast  1  minute.  Precautions  were  taken  not  to  repalpate  the  vein.  The 
venepuncture  site  was  then  punctured.  In  adults  ,5ml  of  blood was  drawn 
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aseptically and  the blood was transferred  to the blood culture bottle with 
50ml  of   BHI  broth  swabbing the  cap with  70% alcohol  .Blood was  then 
inoculated into the bottle through the hole  in  the cap.  The  caps were then 
secured tightly. In children, 1-2ml of blood was collected  similiarly in 20ml of 
sterile BHI broth in blood culture bottles. If the infant had an existing IV line, 
blood was drawn below the existing line.  In Endocarditis, three samples were 
collected one hour apart. 
                          Pus samples were collected in syringes or swabs.  The  site of 
lesion of the wound was decontaminated with surgical soap and 70% Isopropyl 
alcohol. The wound was then washed with sterile saline and allowed to dry. 
The discharge was then collected in a sterile  syringe.  If  the discharge was 
minimal,  sterile  swabs  were used.  The wound margins  were separated and 
swabs were taken from the depth of the wound. Care was taken not to involve 
the  skin  margins.  Two  swabs  were  taken,  one  for  direct  microscopic 
examination and the other for culture. 
Urine samples were collected by sampling the mid stream flow 
by  the  clean  catch  technique.  Appropriate  instructions  were  given  to  the 
patients and the specimen was collected in a wide mouthed container. 
CSF was collected in cases with meningitis. Spinal tap was done 
with the assistance of an experienced physician. The patient was asked to lie 
on his or her side. The area overlying the lumbar spine was disinfected and 
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CSF was collected by introducing a spinal needle between L3 and L4 lumbar 
spaces. 
TRANSPORTATION OF SPECIMEN:
After collection, the samples were checked for proper labelling like Patient’s 
name,  age  sex,  IP/OP  Number.  All  the  clinical  samples  collected  were 
transported to the Microbiology laboratory within 1 hr of collection.
PROCESSING OF SPECIMENS:
In the Microbiology Laboratory, the specimens were checked for 
any leakage (or) damage. The macroscopic appearance of the specimens such 
as  colour,  turbidity  and  odour  were  noted.  Blood  culture  bottles  were 
incubated at 37oC for 48 hrs. Direct microscopic examination was done for Pus 
and CSF samples. The smears prepared from the above samples were stained 
with Gram’s stain and observed under the microscope. The  specimens were 
plated on Nutrient Agar, MacConkey and Blood Agar plates and incubated at 
37oC overnight.  The colony morphology on the plates were then noted. On 
Nutrient Agar plate, entercoccus colony was small 0.5 – 1 mm transparent, low 
convex,  discrete  with  glossy  surface.  On MacConkey  Agar,  they  produced 
0.5-1mm  sized,  magenta  coloured  lactose  fermenting  colonies.  Blood  agar 
plate showed α, β, or γ hemolysis. The colonies with the above  characteristics 
were  presumed  to  be  enterococcus.  Further  confirmation  of  the  isolate  as 
Enterococcus was done by Gram’s stain, Catalase test, Bile Esculin hydrolysis, 
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Heat resistance and Salt tolerance test. In Grams stain, Enterococci  appeared 
as Gram positive cocci arranged in  pairs and short chains with a characteristic 
leaf shape.  Further the organisms were found to be catalase negative . The 
culture was then inoculated onto Bile esculin agar plates and incubated at 370C 
for 48 hrs. Enterococci and group D Streptococci produced blackening of the 
agar plates.. The organisms were further subjected to heat test. For this test, 2 
or 3  of the isolated colonies were inoculated into glucose broth and incubated 
at 37o C overnight. The growth was judged with the turbidity, sub cultured 
from the broth onto one half on a nutrient agar plate, then the broth was placed 
in a water bath set at 60o C for 30 minutes. Sub culture was done from the 
broth on the other half of the nutrient agar medium. After incubation at 37o C 
for 24 hrs, growth was observed on both halves of the plate, which indicates 
the heat resistant property of Enterococci.Next salt  tolerance test was done. 
This is based on the ability of the Enterococci to grow in the presence of 6.5% 
NaCl  incorporated  into  broth/agar  while  other  Group  D  Streptococci  are 
negative for this test.
The  enterococcus  isolates  were  further  speciated  into  E.  faecalis,  E. 
faecium and E. durans depending upon the fermentation of sugars, motility, 
arginine  decarboxylation,  pigmentation,  reduction  of  tellurite  and  using 
selective  media.  The  common  sugars  used  were  Arabinose,  Raffinose, 
Sucrose,  Sorbitol  and  Mannitol. For  sugar  fermentation  test,  Todd-Hewitt 
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broth  with the 1% sugar and  bromothymol blue as indicator was used. Each 
tube was inoculated with 2 drops of an 18-24 hrs brain-heart infusion broth 
culture and incubated at 37oC for 24-48 hrs and observed for colour change 
from blue  to  yellow.Pyruvate  fermentation  was  tested  by  inoculating  fresh 
culture into pyruvate broth and incubated at 37oC for 24-48 hours. Change in 
color from blue to yellow showed fermentation of pyruvate.
  All the three species did not ferment Raffinose . Arabinose was fermented by 
E.  faecium.  Pyruvate  was  fermented  by  only  E.  faecalis.  The  above  three 
species were found to be non motile by hanging drop and by Mannitol motility 
medium. 
All  the   above  three   species  of  Enterococcus  deaminated  the  aminoacid 
Arginine to ammonia resuting in alkalinization of the medium thus changing 
the colour from yellow to purple. 
Pigmentation produced was tested by touching the colony grown on Trypticase 
Soy  Agar  with  a  Dacron  swab  and   noting  whether  yellow  pigment  was 
produced or not. All the three species, E. faecalis, E. faecium and E. durans did 
not produce any pigmentation. The isolates were then tested for reduction of 
tellutrite.The  medium used  was  human  blood  agar  plate  incorporated  with 
0.04% pottasium tellurite. The isolated colonies were streaked on the plate, 
incubated  at  37o C  for   24-48  hours. Enterococcus  faecalis  isolates  were 
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identified by the brownish black colored colonies.The other two species did 
not reduce potassium tellurite into metallic tellurium.
The identification of the three species were done as follows:
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E. faecalis - - - +- + - + + + +
E. faecium - + - v - + - + -
E. durans - - - - - - - + -
The  selective  media  used  was  Hicrome  Enterococcus  agar  base  with 
Arabinose,  Chromogenic  substrate,  peptone  and  corn  starch  as  main 
ingredients,  phenol  red  as  indicator  with  added  E.faecium  Selective 
Supplement. E. faecium was identified by the conversion of the colonies into 
green colour with the surrounding medium changing yellow due to arabinose 
fermentation. E. faecalis produced blue colour colonies.E. durans did not show 
any change.
The different  species  of enterococci were further subjected to antimicrobial 
susceptibility testing by the Kirby Bauer Method . The antibiotics used were 
Erythromycin,  Ampicillin,  High  level  Gentamycin,  Ciprofloxacin, 
Doxycycline,Nitrofurantoin,Ceftriaxone ,Cefataxime and Vancomycin. A few 
colonies  of  the  isolates  were  inoculated  into  peptone  water,  which  was 
standardized to a density equivalent to 0.5 McFarland opacity. The inoculum 
was then spread across the surface of Mueller Hinton agar plate of 9 cm. size 
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to  give  a  confluent  growth.Filter  paper  discs  of  6  mm size  containing  the 
specific concentration of the antibiotics were placed on the agar surface 24 mm 
apart. Six discs were kept on the surface of the plate at a time. The plates were 
incubated over night at 37oC for 24-48 hrs. After incubation the diameter of 
the  zone  of  growth  inhibition  was  measured  by  a  graduated  ruler  and the 
sensitivity and resistant pattern were identified as follows:
S. No Antibiotic
Disc 
content
Zone of inhibition (mm)
Sensitive Resistant
1 Ampicillin 10 µg ≥ 17 ≤ 16
2 Gentamycin 120 µg ≥ 10 6
3 Ciprofloxacin 5 µg 21 15
4 Nitrofurantoin 300 µg ≥ 17 ≤ 14
5 Doxcycline 30 µg 16 12
6 Erythromycin 15 µg ≥ 18 ≤ 13
7 Ceftriaxone 30 µg > 21 ≤ 13
8 Cefataxime 30 µg > 23 ≤ 14
9 Vancomycin 30 µg ≥ 17 ≤ 14
The principle, procedure and interpretation of the tests are given in 
the annexure-1.
RESULTS
In this study, a total of 200 samples, 50 samples each from Paediatrics, 
Surgery , Medicine and Urology ward at Govt. Rajaji Hospital were collected 
and  analysed   for  the  Species  of  enterococcus  commonly  involved  in  the 
infections of this hospital , the age group and sex commonly affected by this 
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species  of  enterococcus,  the  common  infection  occurring  in  the  patients 
affected  by  this  species  and  the  most  common  factor  responsible  for  the 
occurrence of this infection in this hospital.
 The 200 samples collected were analysed age and sex wise. 
Out of the 30 samples collected between the age group 0-1month ,19(63.3%) 
were from males and 11 (36.6%)were from females. Out of the 12 samples 
collected between the age group 1 month-12months , 8(66.6%) were males and 
4(33.3%) were females. Out of 8 samples from the age group 1-12 years, 4 
(50%)  samples  each  were  collected  from  males  and  females.  Out  of  50 
samples collected between the age group 13-33 yrs, 16 (32%) were from males 
and 34 (68%) were from females. Out of 80 samples from the age group 34-54 
yrs, 38 (47.5%) were from males and 42 (52.5%) were from females. Above 
the age group of 54 yrs, 20 samples were collected, out of which 12 (60%) 
were from males and 8 (40%) were from females.  .  It was found that in 
males,  more number of samples were collected  in the age group 1 month 
to 12 months and in females between the age group 13- 33 years.. The age 
and sex distribution of samples are given in Table 1
TABLE 1: AGEWISE AND SEXWISE DISTRIBUTION OF SAMPLE
S.No. Patient Age Number Sex Number %
1. 0-1 month 30 Male 19 63.3%
Female 11 36.6%
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2. 1 month – 12 
months
12 Male 8 66.6%
Female 4 33.3%
3. 1-12 yrs 8 Male 4 50%
Female 4 50%
4. 13-33 yrs 50 Males 16 32%
Female 34 68%
5. 34-54 yrs 80 Male 38 47.5%
Female 42 52.5%
6. >54 yrs 20 Male 12 60%
Female 8 40%
Total 200 200
Among the 200 samples, 50 samples were collected from the 
Paediatric ward. Out of the 50 samples collected, 24 (48%) were   urine, 
24(48%) were  blood, 1 each from CSF and pus (2% each). Among the 50 
samples collected from the General Surgery, 8(16%) were Urine, 12(24%) 
were blood, 17(34%) were Pus, 13(26%) were  Swab and there was no CSF 
sample. Among the 50 samples collected from the Medical ward, 19(38%) 
were Urine, 26(52%) were blood, 4(8%) were CSF and 1(2%) was from 
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Pus .From Urology ward, a total of 50 samples were collected, out of which 
33(66%) were from Urine,  17(34%) were Blood and there  was  no pus/ 
swab/ CSF.. The distribution of samples ward wise and specimen wise is 
given in Table no.2 
TABLE 2 
WARDWISE AND SPECIMEN WISE DISTRIBUTION OF SAMPLE
S.No Ward Total no 
of 
Specimens 
Specimen
Urine Blood CSF PUS Pus/Wound 
Swab
1 Pediatric 50 24 
(48%)
24(48%) 1(2%) 1(2%) -
2 General 
Surgery
50 8(16%) 12(24%) - 17(34%) 13(26%)
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3 Medicine 50 19(38%) 26(52%) 4(8%) 1(2%) -
4 Urology 50 33(66%) 17(34%) - - -
Total 200 84(42%) 79(39.5%) 5(2.5%) 19(9.5%) 13(6.5%)
It  was  found  that  urine  and  blood  were  the  common 
specimens collected in pediatric ward, pus and swab in general surgery 
ward, blood in medical ward and urine in urology ward. 
All the 200 samples were subjected to gram staining. It was 
found that 71 out of 200 (35.5%) were gram positive cocci. The samples were 
further  analysed  ward  wise  and specimen  wise  as  per  Gram reaction.  The 
percentage of Gram positive cocci isolated from Pediatrics, General surgery, 
Medicine and Urology wards was 52% (26 out of 50), 28% (14 out of 50), 
26% (13 out  of  50) and 36% (18 out  of  50) respectively.  Thus wardwise 
distribution  showed  that  more  number  of  Gram  positive  cocci  were 
isolated from the Pediatric  ward.  The percentage of  Gram positive cocci 
isolated from Urine, Blood, Pus, Swab and CSF was 23.8% (20 out of 84), 
54.4% (43 out of 79), 21% (4 out of 19), 23% (3 out of 13) and 20% (1 out of 
5) respectively.  Thus specimenwise distribution showed that more Gram 
positive cocci  were isolated from blood.  The wardwise and specimenwise 
distribution of Grampositive cocci are given in Table no.3 and  4
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TABLE 3
WARDWISE DISTRIBUTION OF GRAM POSITIVE COCCI
S.No Ward Total no of 
sample 
collected
Gram Positive 
Cocci
%
1. Pediatric Ward 50 26 52%
2. General surgery Ward 50 14 28%
3. Medicine Ward 50 13 26%
4. Urology Ward 50 18 36%
         TOTAL 200 71
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TABLE 4
SPECIMENWISE DISTRIBUTION OF GRAM 
POSITIVE COCCI
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S.No Specimen Total No of 
specimen 
collected
Gram 
positive 
cocci
%
1 URINE 84 20 23.8%
2 BLOOD 79 43 54.4%
3 PUS 19 4 21%
4 SWAB 13 3 23%
5 CSF 5 1 20%
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Total 200 71
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All  the  71  Gram positive  cocci  were  processed  for  the  presence  of 
enterococcus and by confirmation using the various tests and it was found that 
36 out of 71 (50.7%) were Enterococci. The other Gram positive cocci isolated 
were  Coagulase  Negative  Staphylococci  (CONS)  24  (33.8%)  and 
Staphylococcus aureus 11 (15.4%). Sexwise  analysis of the 36 enterococcal 
isolates showed that in Pediatric ward,7 out of 12 isolates were from males 
(58.3%) and 5 were from females  (41.6%) In general  surgery,among the 8 
enterococcus isolates, 5 (62.5%) were males and 3 (37.5%) were females. In 
medical ward, out of  6 isolates 4 (66.6%) were males and 2 (33.3%) were 
females.  In  the urology ward,out  of  10 enterococcus  isolates,  4  were from 
males(40%) and 6 were from females(60%).Analysis of sexwise distribution 
of enterococcus isolates showed that males predominated in all the wards 
except urology where the females predominated. The isolates were analysed 
wardwise  and  it  was  found  that  12(33.3%)  were  from  pediatric  ward,  8 
(22.2%),were from Surgery ward,6(16.6%) were from Medical ward and 10 
(27.7%) were from Urology ward.  Thus maximum number of  isolates of 
enterococcus were from  Pediatric ward. Wardwise and sexwise distribution 
of enterococcus isolates is given in Table no.5. 
TABLE 5
WARDWISE AND SEXWISE DISTRIBUTION OF ENTEROCOCCUS
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S.No. Ward Total 
Number
Sex Number %
1. Pediatric 12 Males 7 58.3%
Females 5 41.6%
2. General 
Surgery
8 Males 5 62.5%
Females 3 37.5%
3. Medicine 6 Males 4 66.6%
Females 2 33.3%
4. Urology 10 Males 4 40%
Females 6 60%
36 36
The 36 enterococal isolates were further analysed agewise. It was noted 
that 10(27.7%) out of 36 were in the age group 0-1 month , 3(8.3%) were in 
the age group of 1 month – 12 months ,  2 (5.5%)  were between 1 – 12 yrs, 
7(19.4%) were in the age group of 13 – 33 yrs,  8(22.2%)  were in the age 
group 34 – 54 yrs and 6(16.6%)  were in the age group more than 54. It was 
noted that maximum number of isolates of enterococcus were between the 
age group 0-1 month. The agewise distribution of enterococcus is given in 
Table 6.
TABLE 6
AGE WISE DISTRIBUTION OF ENTEROCOCCUS
PATIENT’S AGE 
IN YEARS
NUMBER
%
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0-1 month 10
27.7%
1 month – 12 
months
3 8.3%
1 – 12 yrs 2 5.5%
13 - 33yrs 7 19.4%
34 – 54 yrs 8 22.2%
> 54 yrs 6 16.6%
The enterococcus species were analysed specimenwise and it  was found 
that  out  of  the  36  Enterococcal  isolates,  14  (38.8%)  were  from urine,  20 
(55.5%) were from blood, 1 (2.7%) was from pus, 1 (2.7%) was from Swab 
and  no  isolate  from CSF.  Thus  maximum  number  of  enterococci  were 
isolated  from blood  samples.   Specimenwise  distribution  of  enterococcus 
isolates is given in Table 7.  
TABLE 7
DISTRIBUTION OF ENTEROCOCCI SPECIMEN WISE
SPECIMEN Number isolated PERCENTAGE
URINE 14 38.8%
BLOOD 20 55.5%
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PUS 1 2.7%
SWAB 1 2.7%
CSF - -
Total 36 50.7%
Inpatient and outpatient analysis of Enterococcal isolates showed that 28 
out  of  36(77.7%) were from Inpatients  and 8 out  of  36(22.2%) were from 
outpatients thus showing inpatient predominance .The incidence of inpatient 
and out patient enterococcus isolates is  given in Table no.8
Table – 8
INCIDENCE OF ENTEROCOCCUS -  INPATIENT, OUTPATIENT
IP/OP NO. OF ISOLATES PERCENTAGE
Inpatient 28 77.7%
Outpatient 8 22.2%
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Enterococcus  were  speciated  into  E.faecalis,  E.faecium and  E.durans 
according to the biochemical reactions and it was found that  out of the 36 
Enterococcus isolates,  15(41.6%) were E.faecalis,18 (50%) were E.faecium, 
and 3 (8.3%) was E.durans. Thus the most common species of enterococcus 
isolated was E.  faecium.  The species  wise  distribution of  Enterococcus  is 
given in Table no:9
TABLE 9
SPECIES WISE DISTRIBUTION OF ENTEROCOCCUS
SPECIES ISOLATES IN 
NUMBER
PERCENTAGE
E.faecalis 15 41.6%
E.faecium 18 50%
E.durans 3 8.3%
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The three species were analysed age wise and it was found that in the 
age group 0-1 month 9(90%) were E.faecium, 1(10%) was E.durans. In the age 
group  1  month  –  12  months  1(33.3%)  was  E.faecalis  and  2(66.6%)  were 
E.faecium. In the  age group 1-12 years 1(50%) was E.faecalis and 1(50%) 
was  E.faecium.  In  the  age  group  13-33  years  5(71.4%)  were  E.faecalis, 
1(14.2%) was E.faecium and 1(14.2%) was E.durans. In the age group 34-54 
years  4(50%) were E.faecalis,  3(37.5%) were E.faecium and 1(12.5%) was 
E.durans. In the age group more than 54years 4(66.6%) were E.faecalis and 
2(33.3%) were E.faecium. It was found that 50%  were E. faecium isolates 
and it was commonly found in the age group between 0-1 month. Agewise 
distribution of enterococcus species is given in Table no.10.
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TABLE - 10
AGEWISE DISTRIBUTION OF ENTEROCOCCUS SPECIES
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S.No Age
Total no. of 
enterococcus 
isolates
E.faecalis E.faecium E.durans
Total 
Number
% Total 
Number
% Total 
Number
%
1 0-1 
month 
10 - - 9 90% 1 10%
2 1– 1 
months
3 1 33.3% 2 66.6% - -
3 1yr – 
12 yrs 
2 1 50% 1 50% - -
4 13- 33 
yrs 
7 5 71.4% 1 14.2% 1 14.2%
5 34 – 
54 yrs
8 4 50% 3 37.5% 1 12.5%
6 > 54 
yrs 
6 4 66.6% 2 33.3% - -
Total 36 15 41.6% 18 50% 3 8.3%
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The  sexwise  distribution  shows  that  in  pediatric  ward  out  of  7  males 
1(14.2%)  was  E.faecalis,  5(71.4%)  were  E.faecium  and  1(14.2%)  was 
E.durans. In Surgery ward out 4 males 3(75%) were E.faecalis, 1(25%) was 
E.faecium and no E.durans.  In Medicine ward out  of  4 males 2(50%) was 
E.faecalis, 1(25%) was E.faecium and 1(25%) was E.durans. In Urology ward 
out  of  4  males  1(25%)  was  E.faecalis,  3(75%)  were  E.faecium  and  no 
E.durans. In pediatric ward out 5 females 1(20%) was E.faecalis,  4(80%) were 
E.faecium and no E.durans. In Surgery ward out of 4 females 2(50%) were 
E.faeclis, 2(50%) were E.faecium and 1(25%) was E.durans. In Medicine ward 
out of 2 females 1(50%) each were E.faeclis and E.faecium. In Urology ward 
out  of  6  females  5(83.3%)  were  E.faecalis  and  1(16.6%)  was  E.faecium. 
Sexwise distribution of enterococcus species is given in Table no.11.
TABLE 11
SEXWISE DISTRIBUTION OF ENTEROCOCCUS SPECIES
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Ward Sex
    Total 
entero 
coccus
E.faecalis E.faecium E.durans
Total 
Number
% Total 
Number
% Total 
Number
%
Pediatric Male 7 1 14.2% 5 71.4% 1 14.2%
Female 5 1 20% 4 80% -
Surgery Male 4 3 75% 1 25%
Female 4 2 50% 2 50% 1 25%
Medicine Male 4 2 50% 1 25% 1 25%
Female 2 1 50% 1 50% -
Urology Male 4 1 25% 3 75% -
Female 6 5 83.3% 1 16.6% -
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The three different species were analysed wardwise and it was found that in 
Paediatric ward, out of 12 isolates 2(1.8%) were E. faecalis, 9(75%)  were E. 
faecium,  1(2.7%)  was  E.  durans.  In  Surgery  out  of  8  cases  4(50%)  were 
E.faecalis,  3(37.5%)  were  E.faecium  and  1  (12.5%)  was  E.durans.  In 
Medicine, out of 6 isolates 3(50%) were E.fecalis, 2(33.3%) were E.faecium 
and  1(16.6%)  was  E.durans.  In  Urology,  out  of  10  isolates  6(60%)  were 
E.faecalis and 4(40%) were E.faecium. It was noted that E. faecium was the 
commonest species found in the pediatric ward.  Wardwise distribution of 
enterococcus species is given in Table no.12.
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TABLE 12
WARDWISE DISTRIBUTION OF ENTEROCOCCUS SPECIES
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S.No Ward
E.faecalis E.faecium E.durans
Total 
Number
% Total 
Number
% Total 
Number
%
1 Pediatric 
(12)
2 1.8% 9 75% 1 2.7%
2 General 
Surgery (8)
4 50% 3 37.5% 1 12.5%
3 Medicine 
(6)
3 50% 2 33.3% 1 16.6%
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4 Urology 
(10)
6 60% 4 40% - -
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The three species of Enterococci were further analysed specimenwise and it 
was found that in urine 10(27.7%) out of 36 were E. faecalis, 2(5.5%)  out of 
36 were E. faecium, 2(5.5%) out of 36 was E. durans. In blood, 4(11.1%) out 
of 36 was E. faecalis, 14(38.8%) out of 36 were E. faecium and 1(2.7%) was 
E. durans. In pus, 2(5.5%) was E. faecium and in swab 1(2.7%) was E. faecalis 
Thus  it  was found that E. faecium was isolated more from blood and 
E.faecalis more in urine.  Specimenwise distribution of the three species of 
Enterococci is given in Table no. 13
         
TABLE 13
SPECIMENWISE  DISTRIBUTION OF ENTEROCOCCUS SPECIES
SOURCE E.faecalis E.faecium E.durans
URINE 10 / 36 
(27.7%)
2/ 36 
(5.5%)
2/ 36 
(5.5%)
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BLOOD 4 /36 
(11.1%)
14 /36 
(38.8%)
1/36 
(2.7%)
PUS - 2 /36 
(5.5%)
-
SWAB 1 /36
(2.7%)
-
Total 15/36
(41.6%)
18/36 
(50%)
3/36
(8.3%)
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The susceptibility and resistance patterns of Enterococci were studied. Out of 
18  E.faecium isolates, 17 (94.4%) were resistant to Ampicillin, 12 (66.6%) to 
Gentamycin, 13 (72.2%)  to Ciprofloxacin, 11 (61.1%)  to Doxycycline, 13 
(12.2%)  to Nitrofurantion,  1 (5.5%)  to Vancomycin,  18 (100%)  to both 
Ceftaxime and ceftrioxone, 12 (66.6%)  to Erythromycin.
Out of 15 E.faecalis,  13(86.6%) were resistant Ampicillin,  6(40%) to 
Gentamycin, 4(26.6%) to Ciprofloxacin, 10(66.6%) to Doxycycline, 9(60%) 
to Nitrofurantion, 7 (46.6%) to Erythromycin. All 15 isolates were resistant to 
Ceftriaxone and Ceftaxime and all were sensitive to Vancomycin.
Out  of  3  E.durans,  100%  resistance  were  seen  with  Ciprofloxacin, 
Cefataxime and Ceftriaxone. All isolates were sensitive to Vancomycin and 
Gentamycin. Out of the 3 isolates 2(66.6%) were resisitant to Doxycycline, 
2(66.6%)   to  Nitrofurantion  ,  1(33.3%)  to  Erythromycin,1(33.3%)  to 
Ampicillin. 
Thus it was found that among all 36 isolates ,100% resistance was to 
Ceftaxime and Ceftriaxone , 50 % resistance to Gentamycin, 88.5% resistance 
to Ampicillin and 2.7 % resistance to Vancomycin. It was noted that among 
the  species,  E.faecium showed more  resistance  than other  species. The 
Antibiotic Sensitivity and Resistance pattern is given in Table 14 and Table 
15.
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TABLE 14
ANTIBIOTIC SENSITIVITY  PATTERN IN 
ENTEROCOCCI SPECIES WISE
Organism
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 E.faecium 18 1
 (5.5%)
6
(33.3%)
5 
(27.7%)
7 
(38.8%)
5 
(27.7%)
17 
(94.4%)
0 
(100%)
0 
(100%)
6 
(33.3%)
 E.faecalis 15 2 
(13.3%)
9 
(60%)
9
 (60%)
5 
(33.3%)
6 
(40%)
15 
(100%)
0
(0%)
0
(0%)
8 
(53.3%)
 E.durans 3 2
(66.6%)
3 
(100%)
0
(0%)
1
(33.3%)
1
(33.3%)
3
(100%)
0
(0%)
0
  (0%)
2
(66.6%)
Total no. of 
isolates
36 5 
(13.8%)
18 
(50%)
14
(38.4%)
13
(36.1%)
12 
(33.3%)
34
(94.4%)
0
(0%)
0
(0%)
16
(44.4%)
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TABLE 15
 ANTIBIOTIC RESISTANCE  PATTERN IN 
ENTEROCOCCI -SPECIES WISE
Organism
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 E.faecium 18 17 
(94.4%)
12 
(66.6%)
13 
(72.2%)
11 
(61.1%)
13 
(72.2%)
1 
(5.5%)
18
(100%)
18
(100%)
12
(66.6%)
 E.faecalis 15 13 
(86.6%)
6 
(40%)
4
(26.6%)
10
(66.6%)
9
(60%)
0
(0%)
15
(100%)
15
(100%)
7
(46.6%)
E.durans 3 1 
(33.3%)
0 
(0%)
3
(100%)
2
(66.6%)
2
(66.6%)
0
(0%)
3
(100%)
3
(100%)
1
(33.3%)
Total no. of 
isolates
36 31
(88.5%)
18
(50%)
20
(55.5%)
23
(63.8%)
24
(66.6%)
1
(2.7%)
36
(100%)
36
(100%)
20
(55.5%)
DISCUSSION
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A total of 200 clinical samples from varied infections of Pediatric, 
General  Surgery,  Medicine  and  Urology  wards  of  Govt  .Rajaji  Hospital, 
Madurai  were  collected  and  analysed  to  find  the  species  of  enterococcus 
commonly isolated from Urine, Blood, CSF, Pus and wound Swab . They were 
further analysed agewise, sexwise and specimenwise to know the common age 
group,sex and the common infection involved by this species of enterococcus 
during a period of 4  months from November  2006 to February 2007.
In the present   study,  among the 200 samples collected it  was 
found  that  42% of  samples  collected  were  from urine  and 39.5% samples 
collected were from blood. This is in accordance with the study by Steven 
Gordan et al who had shown that 57% of their samples were from urine88 and 
Patrick Murray etal who had also shown that 36% of their samples were from 
blood66. As the most common sites for isolation of enterococcus are urinary 
tract  and blood stream,  more  number  of  samples  collected from these  two 
infections are justified. 
In  this  study  52%  Gram  postive  cocci  were  isolated  from 
Pediatric ward in Blood samples. Similar study by  Wisplinghoff et al showed 
that 65% of Gram positive cocci were associated with Pediatric Blood stream 
infection101. L.F. Nimri et al also showed that 53.3% Gram positive cocci were 
in blood samples37. These two studies are in accordance with our study. The 
more incidence of Gram positive organisims isolated from the pediatric ward 
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may be attributed to the extremes of age or due to invasive procedures like 
intravenous infusion or  may be due to  inappropriate antibiotic usage.  The 
common occurrence  of gram positive cocci in blood may be attributed to the 
entry of these organisims through the intravenous route from other sources like 
urine, motion etc. because most of these children had the infusion line in their 
lower extremeties. 
In this study it was observed that 50.7% of Gram postive cocci 
isolated  from  various  infections  were  enterococcus  species.  This  is  in 
accordance  with the study of  Louis  B.  Rice  etal  who also  had shown that 
Enterococcus infection  was responsible for more than 40% in their study on 
various  infections41.  The  higher  incidence  of  Enterococcus  among  Gram 
positive cocci may be due to the properties involved in the adherance to host 
tissue  which  are  considered  as  important  virulent  factors  for  establishing 
infection by Enterococci. Also enterococci are intrinsically resistant to a wide 
range of antibiotic which notably include  β - lactams and Aminoglycosides 
frequently used to treat infections with Gram positive organisms. Also they 
have ability to acquire resistance to antimicrobial agents through plasmids and 
transposons and chromosomal exchange or mutation.
                        Age wise distribution of enterococcus in this study 
showed that 33.3% of them were from the paediatric ward and 27.7% of the 
enterococci isolated in pediatric ward were between the age group 0-1 month . 
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This is in accordance with the study by Al Otaibi et al who had  reported 30% 
of  Enterococcal  bacteremia  in  neonates5. The  occurrence  of  enterococcal 
bacteremia  in  neonates  is  obvious  because  of  their  poor  development  of 
immune system and emergence of virulent antimicrobial resistant enterococci 
in  pediatric  wards  due  to  the  constant  wetting  of  beds  by  neonates  and 
irrelevant usage of antibiotics in these wards. In this study, in the paediatric 
ward,  86.3%  males  showed  enterococcus  whereas  only  13.7  %  females 
showed enterococci. Similar study by A.S.M. Nawshad Uddin Ahmed in their 
analysis  of  cases  had  reported  that  63%  of  males  were  with  neonatal 
enterococcal  septicemia3.  This  might  be due to the better  natural  immunity 
shown by female children or by hormonal protection rendered to the female 
children.
The  sexwise  distribution  of  Enterococcal  isolates  showed  that 
55.5% were males and 45% were females. In all wards except Urology ,more 
than 50% isolates  were from males   and in Urology ward more  than 50% 
isolates  were  from  females.  Vittal  Prakash  et  al  in  their  study  also 
demonstrated  that  56.5  %  were  males  and  43.5%  were  females98.  The 
increased incidence of enterococcal isolation among females in Urology ward 
may be attributed to the more number of Urine samples collected in ward and 
enterococcus  is  a  known urinary  pathogen.  It  is  more  common  in  females 
mainly due to the anatomical built of the female urethra. The less incidence in 
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males  may  be  due  to  the  drier   environment  surrounding  the  meatus  and 
antibacterial effect of prostatic fluid. 
It was also shown in this study  that 33.3% of Enterococcus were from 
Pediatric  ward  whereas  Wisplinghoff  et  al  has  demonstrated  only  9% 
Enterococci from Pediatric ward101. Louis B. Rice et al in their study proved 
that  relative  proportion  of  enterococcus  infection  had  increased  in  some 
instances to even more than 40%41. This sudden increase might be due to the 
sudden emergence of antibiotic resistant Enterococci in hospitals especially in 
pediatric ward. 
In  this  study,  it  was  observed  that  Enterococcus  was 
commonly isolated in blood (55.5%)  and the same was supported by A.Bedini 
et al  who had reported in their study an incidence of 42.9%  enterococci in 
blood stream infections1. S.Stefani et al also had documented that 41.3% of 
bacteremic cases were due to enterococcus82.Patrick Murray had explained that 
most of the enterococcal bacteremias were of nosocomial origin because the 
enterococcus has the character of showing multiple drug resistance especially 
due to heavy use of antimicrobial agents66.
                It was also observed in this  study that 77.7% of  Enterococcus 
isolated were from inpatients. This in accordance with the study by Martinez 
Odriozola et al  who had reported   that 68% of enterococcal  isolates were 
hospital  accquired51 and   Patterson  et  al  who  had  reported  that  61%  of 
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enterococcal  infections  were  nosocomial67.  The  period  of  study  was  post 
monsoon period in which many diarrhoeal cases were reported in the pediatric 
ward. Obviously, enterococci, a commensal of Gatrointestinal tract would have 
occured as a nosocomial agent in the pediatric ward where neonates with poor 
immunity and heavy doses of irrelevant antibiotics got admitted.
Species  wise  distribution  of  enterococcus  showed  that  50%  of 
enterococcal isolates were E.faecium . It was noted in this study that 75% of 
E.faecium  were  from  the  paediatric  ward  and  90%  of  E.  faecium  in  the 
pediatric ward were in the age group 0-1 month and 71.4 % pediatric cases 
were  in males. This is in accordance with the study by Lata Kapoor etal who 
had  also  isolated  66%  of  E.faecium  from  paediatric  cases  from  males39. 
Prematurity, low birth weight, increased  number of days of hospitalisation , 
treatment via central venous line, parentral nutrition and antibiotic abuse might 
have  attributed to the increased colonisation of neonates by enterococcus. 
Specimen  wise  distribution  showed  that   Blood  was  the 
most common specimen from which it was isolated (38.8%).Similar study by 
M.G Karmarkar etal have reported 80.7% of cases due to E.faecium45. Uma 
Chaudhary et al have stated that E.faecalis was the most common species in all 
clinical  specimen  except  in  blood where  E.faecium was the most  common 
isolate(50%)96. Mohanty et al in their study  recovered 42.9% of E.faecium60, 
which was the predominant isolate from blood wheras E.faecalis was mostly 
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isolated from urine and pus.Thus the above studies correlated well with the 
present  study..  The  increasing  predominance  of  E.  faecium as  a  cause  of 
bloodstream  infections  may  partly  reflect  the  high  rate  of  antimicrobial 
resistance in this species . E.faecium more commonly acquires resistance to 
ampicillin  and  glycopeptides  relative  to  other  enterococcal  isolates.Since 
ampicillin  was one of  the common antibiotic used in our hospital during the 
study period,  the  increased  incidence  of  enterococcus  faecium  during that 
period was justified.
The  present  study  on  antibiotic  susceptibility  pattern  of 
Enterococcus  species  showed  that  E.faecium  was  resistant  to  common 
antibiotics  like  Ampicillin  (94.4%),  Gentamycin  (66.6%),Ciprofloxacin 
(72.2%),  Doxycycline  (61.1%),  Erythromycin  (66.6%)  ,  Nitrofurantoin 
(72.2%)  and Vancomycin  (5.5%).This  is  in  accordance  with   the  study by 
Ujjala et al who showed E.faecium to have resistance to Gentamycin (77.7%), 
Ciprofloxacin  (81%) and Erythromycin(86%)96 but  resistance  to  Ampicillin 
was only 54%. M.G. Karmarkar etal  have documented 85.5% resistance to 
Nitrofurantoin  ,  100% resistance  to  Gentamycin  and  28.57% resistance  to 
Vancomycin45.  All   isolates  showed  100%  resistance  to  Cefotaxime  and 
Ceftriaxone to which enterococci are intrinsically resistant .During the period 
of  study,  the  four  antibiotics  used  in  the  pediatric  ward  were  Ampicillin, 
Gentamycin  ,  third  generation  cephalosporins  and  Vancomycin.  All  these 
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antibiotics were given intravenously through the infusion lines in their lower 
extremities either twice a day or three times a day. Obviously the isolates were 
resistant  to  most  of  the  antimicrobials   as  well  as   to  third  generation 
cephalosprins which were already proved to be a resistant drug. Because of the 
indiscriminate use of antibiotics in the pediatric ward during the study period 
which was post monsoon and epidemics of diarrhoea were very common, the 
emergence of antibiotic resistant E. faecium in this ward was very obvious and 
justified.
75
            SUMMARY
The study on the speciation  of Enterococci in varied infections of GRH 
revealed  that out of 200 samples from varied infections at GRH, 42% were 
urine samples and 39.5 % were blood samples. Among them, 52% were gram 
positive organisms from the pediatric  ward in  blood samples.  Of the gram 
positive organisms, 50.7% were enterococcus isolates and 33.3% among them 
were from pediatric wards.  Males predominated in 55% of the isolates and 
females only in 45%. More than 50% enterococcus were  found in males in all 
wards  except  urology  where  only   females  showed  more  than  50%. 
Enterococci were isolated in 55% of the blood samples, 33.3% of them were 
from pediatric ward, 27.7% in the age group 0-1 month , 58.3% showed male 
predominance  and  77.7  %  were  inpatients.  The  enterococci  on  speciation 
showed that 50% were E. faecium. Analysis of E.species showed that 38.8% 
were from blood, 75% were from pediatric ward, 90% were  in the age group 
0-1 month and 71.4 %  were males. The enterococcus faecium was resistant to 
94.4%  ampicillin,  66.6%  gentamycin  and  100%  ceftriaxone  and  5.5% 
vancomycin. These four antibiotics were the common antibiotics used in the 
pediatric ward during the study perid. As the study period was post monsoon 
when a lot of diarrhoeal cases got admitted in the hospital, and the patients 
were administered with resistant antibiotics, E. faecium would have ocurred as 
a nosocomial pathogen.
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                                             CONCLUSION
• Enterococcal  infections  contributed  to  a  significant  proportion  of 
infection in the population under study.
• The most common species was E.faecium.
• The patients infected with E.faecium were mostly children between 
0-1 months and septicemia was the most common infection.
• Antimicrobial Susceptibility patterns revealed that the organism had 
developed  resistance  to  the  four  antibiotics  used  during  the  study 
period in the wards.
Therefore this study has revealed that Enterococci could emerge as 
a significant agent of  nosocomial infections especially in neonatalogy 
wards  contributing  to  significant  morbidity  and mortality  by  virtue  of 
Multi Drug Resistance. 
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ANNEXURE 1
1. GRAM STAINING:
The Gram stain was prepared as follows:
PRIMARY DYE:
Crystal violet - 10 g
Ammonium Oxalate - 4.25 g
Absolute alcohol - 50 ml
Distilled water  - 500 ml
The  methyl  violet  dye  was  dissolved  in  50  ml  absolute  alcohol  and 
mixed thoroughly. Then Ammonium oxalate 4.25 g was dissolved in 100 ml of 
Distilled  water  and  this  mixture  was  added  to  the  violet  stain  and  finally 
distilled  water  was  added  to  make  500 ml.  The  total  mixture  was  filtered 
before use.
Grams iodine solution consists of the following
Iodine - 25 g
KI - 50g
DW - 500ml
Fifty grams of KI was dissolved in 500 ml of water and then 25 gms of 
I2 was added to that. When iodine is dissolved, the solution was made upto 500 
ml with Distilled water.
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Counter stain used in Grams stain was dilute carbol fuchsin. It consists 
of the following:
Basic fuschin (powder) 5g  
Phenol (Crystalline) 25g
Alcohol (95% of 100% Ethanol) 50ml
The basic fuschin powder was added to alcohol at intervals until it was 
fully dissolved.  Then phenol too was dissolved in distilled water.  Both the 
solution were mixed in a separate container.
2. CATALASE TEST:
Done by both slide & tube methods.
Tube method:
A small amount of the culture was picked up from the nutrient agar plate 
with  a  clean,  sterile  glass  rod  and  inserted  into  a  tube  of  3%  hydrogen 
peroxide, there was no effervescence or bubbles formation.
Slide method :
Pure growth of the organism from the agar was transferred to a clean 
slide  with  a  sterile  glass  rod.  Immediately  2  to  3  drops  of  3% hydrogen 
peroxide was added to the growth, observed for the release of the bubbles.
3. BILE ESCULIN HYDROLYSIS TEST
This reaction presumptively identifies Group D Streptococci
Meat extract 3 gms
Peptone 5 gms
Ox bile purified and dehydrated 1 gm
Ferric ammonium citrate .5 gm
NaCl 5 gm
Agar 15 gm
Distilled water 1 litre
Using the above ingredients, bile esculin plates were prepared.
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The culture was inoculated onto the plate and incubated at 370C for 48 
hrs. Enterococci and group D Streptococci produced blackening of the agar 
slant.
4. SALT TOLERANCE TEST
This is based on the ability of the Enterococci to grow in the presence of 
6.5% NaCl  incorporated  into  broth,  while  other  Group  D Streptococci  are 
negative for this test. 6.5% NaCl broth was prepared with the following:-
Heart infusion broth 25g
Sodium chloride 65 gm
Indicator (1.6 g of bromothymol
Blue in 100ml of 95% ethanol) 1 ml
Glucose 1 gm
Distilled Water 1 Litre
Dispensed  into  tubes  of  5ml  volume,  autoclaved  at  121o C  for  15 
minutes.  2 to 3 colonies were inoculated into the broth, incubated at 35o C 
overnight in ambient air incubator. It showed turbidity with color change of 
the  medium  from  blue  to  yellow  because  of  acid  production  by  glucose 
fermentation.
5. HEAT RESISTANCE TEST
This is based on the principle that Enterococci can withstand heating at 
60o C for 30 minutes. This differentiates Enterococci from other Streptococci.
For this test, the isolated colonies 2 or 3 were inoculated into glucose 
broth, incubated at 37o C overnight. The growth was judged with the turbidity, 
sub cultured from the broth onto one half on a nutrient agar plate, then the 
broth was placed in a water bath set at 60o C for 30 minutes. Sub culture was 
done  from the  broth  on  the  other  half  of  the  nutrient  agar  medium.  After 
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incubation at 37o C for 24 hrs, growth was observed on both halves of the 
plate, which indicates the heat resistant property of Enterococci.
6. SUGAR FERMENTATION TEST:
Todd Hewitt broth  with bromothymol blue as indicator was used. Each 
tube was inoculated with 2 drops of an 18-24 hrs Todd Hewitt broth culture, 
incubated at 37o C in ambient air for 24-48 hrs. The tube was observed for 
color change from blue to yellow.
The following 1 % sterile sugars  were used;
• Arabinose
• Raffinose
• Sucrose
• Sorbitol
• Mannitol
7. PYRUVATE FERMENTATION
With the following ingredients the pyruvate broth was prepared:-
Tryptone 10g
Yeast extract 5g
K2HPO4 5g
NaCl 5g
Sodium pyruvate 10g
Bromothymol blue 0.1 g
Distilled Water 1 Litre
pH adjusted to 7.2, sterilised at 121oC for 15 minutes. Fresh culture was 
inoculated into pyruvate broth, incubated at 37oC for 24-48 hours. Change in 
color from blue to yellow showed fermentation of pyruvate.
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8. ARGININE DIHYDROLASE TEST
Arginine is first converted to citrulline by means of dihydrolase, then 
undergoes decarboxylation to form putrescine.
Moller’s arginine decarboxylase medium was prepared as follows:
Peptone 5g
Beef Extract 5g
Bromocresol Purple 0.01g
Cresol Red 0.005g
Pyridoxal 0.005g
Glucose 0.5g
Distilled Water 1 Litre
The  solids  were  dissolved  in  water  and the  pH was  adjusted  to  6.0 
before  the  addition  of  the  indicators.  To  this  is  added  1  %  L-arginine 
hydrochloride. Readjusted the pH to 6.0. Distributed 1 ml quantities in small 
tubes, autoclaved at 121o C for 15 minutes.
Well  isolated  colonies  were  inoculated  into  two  tubes  of  Moller’s 
decarboxylase medium, one with the amino acid and another devoid of amino 
acid as a control tube, overlaid both tubes with sterile mineral oil to 1cm and 
incubated at 37oC for 4 days.
Conversion  of  the  control  tube  to  yellow  color  indicated  that  the 
organism is  viable  and pH has  been lowered to  activate  the  decarboxylase 
enzyme. Change in color of the medium from yellow to purple indicates amino 
acid  has  been  deaminated  to  ammonia  resulting  in  alkalinisation.  Negative 
reaction  was  medium  remaining  yellow.  The  control  tube  also  remained 
yellow.
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9. MOTILITY BY
i) Hanging drop method
ii) Semisolid motility medium(Mannitol motility medium)
Using mannitol  medium with 0.2% agar  and 1% mannitol,  organism 
stabbed  once  to  half  depth  in  tubes  with  straight  wire.  Examined  after 
18-24hours  of  incubation  at  37oC,  for  motility.  Motile  bacteria  showing 
diffuse, hazy growth throughout the medium and non-motile bacteria growing 
only in the stabline, sharply defined margins leaving the surrounding  medium 
clear. Further fermentation of mannitol to form acid also could be detected.
10 . HICROME ENTEROCOCUS AGAR BASE:
Hicrome Enterococcus faecium agar purchased from Himedia was used for the 
chromogenic differentiation of Enterococcus .
Ingredients Grams/Litre
Peptone, special 23.0
Corn starch 1.0
Sodium chloride 5.0
Chromogenic sbstrate 0.1
Arabinose 10.0
Phenol red 0.1
Agar 15.0
Final pH (at 25oC) 7.8 + 0.2
E. faecalis produced blue colour colonies
E.  faecium  produced  green  coloured  colonies  with  the  surrounding 
medium turning yellow in colour due to arabinose fermentation.
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PROFORMA
CASE HISTORY
Name : Address:
Age :
Sex :
Occupation :
Education :
Income :
IP No. :
Ward No. :
Diagnosis :
Date of admission :
Date of discharge :
Complaints :
Fever : Continuous, intermittent, low grade, 
        High grade, associated with chills / sweating.
Cough : Productive/nonproductive,diurnal variation
Sputum : Colour, purulent, non purulent, foul 
smelling, blood  stained.
Pus : Colour, discharge – watery, purulent, blood 
stained.
Present history :
Past history : H/O  DM,  HT,  Anaemia,  Jaundice, 
Convulsions.
GENERAL EXAMINATION :
SYSTEMIC EXAMINATION :
CVS :
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RS :
Per abdomen :
CNS :
TREATMENT  DETAILS :
Antibiotics /  Immuno Suppressives / Any Interventions/ Surgery  
  
OUTCOME                      : Cured / Improved/ Worsened / death.
MICROBIOLOGICAL REPORT :
Specimen : PUS/Blood/Sputum/CSF/Urine/Other 
Body Fluids
Lab number :
Date :
Time :
TESTS DONE
       A.    Direct smear    :
       B.   Culture  :
     Nutrient Agar  :
  MacConkey  Agar :
               Blood Agar             :
   Bile Esculin Agar   :
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Catalase Test :
Hanging drop :
6.5% Nacl  Agar  :
Heat Test   :
TESTS FOR SPECIATION
Sucrose Fermentation    :
Mannitol  Fermentation  :
Arabinose Fermentation :
Raffinose Fermentation  :
Sorbitol Fermentation    :
Pyruvate Fermentation :
          HiChrome Enterococcus faecium Agar :
          Pottassium Tellurite Agar   :
          Pigmentation :
ANTIBIOGRAM :
FINAL REPORT :
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